Search company, investor...
Amyris company logo


Founded Year




Total Raised


Market Cap


Stock Price




About Amyris

Amyris (NASDAQ: AMRS) is building an integrated renewable products company by applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. Amyris Brasil, a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil, including SMA Industria Quimica, its joint venture with Sao Martinho. In addition, Amyris is building fuel distribution capabilities in the United States through its subsidiary, Amyris Fuels.

Headquarters Location

5885 Hollis Street Suite 100

Emeryville, California, 94608,

United States


Missing: Amyris's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Amyris's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Amyris

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Amyris in 1 CB Insights research brief, most recently on May 25, 2021.

Expert Collections containing Amyris

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Amyris is included in 3 Expert Collections, including Synthetic Biology.


Synthetic Biology

687 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.


Renewable Energy

2,914 items

Includes companies working on technology to support renewable energy generation.



3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Amyris Patents

Amyris has filed 146 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Virus families
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Transcription factors, Genetics, Biotechnology, Gene expression


Application Date


Grant Date



Related Topics

Molecular biology, Transcription factors, Genetics, Biotechnology, Gene expression



Latest Amyris News

AMRS, NB among notable basic materials additions to Russell microcap; URG, WWR removed

May 24, 2023

Notable additions: Amyris ( AMRS ), Niocorp Developments ( NB ), I-80 Gold ( IAUX ), Nextplat ( NXPL ) and Contango Ore ( CTGO ) Notable deletions: UR Energy ( URG ), Westwater Resources ( WWR ), Comstock ( LODE ), Gatos Silver ( GATO ) and Hycroft Mining ( HYMC ). Changes effective from June 26, after the markets open. Recommended For You To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Amyris Frequently Asked Questions (FAQ)

  • When was Amyris founded?

    Amyris was founded in 2003.

  • Where is Amyris's headquarters?

    Amyris's headquarters is located at 5885 Hollis Street, Emeryville.

  • What is Amyris's latest funding round?

    Amyris's latest funding round is PIPE - II.

  • How much did Amyris raise?

    Amyris raised a total of $341.6M.

  • Who are the investors of Amyris?

    Investors of Amyris include Paycheck Protection Program, Bill & Melinda Gates Foundation, TotalEnergies, Temasek, GrupoCornelioBrennand and 9 more.

  • Who are Amyris's competitors?

    Competitors of Amyris include Viridos, Erbi Biosystems, Solugen, Enerkem, Allozymes, Hyasynth Bio, Lynntech, Demetrix, TerraVia, Synlogic and 13 more.

Compare Amyris to Competitors

Viridos Logo

Viridos develops and commercializes genomic-driven solutions to address global energy and environmental challenges. It builds a platform for low-carbon-intensity biofuels that can reduce greenhouse gas emissions from aviation, commercial trucking, and maritime shipping. The company was formerly known as Synthetic Genomics. It was founded in 2005 and is based in La Jolla, California.

WHEB Biofuels

WHEB Biofuels Limited aims to be a biofuels producer that also invests in biofuels technologies

Biodiesel Technologies

Biodiesel Technologies offers biodiesel processor equipment

Praj Logo

Praj Industries Limited is a Biofuels Technology Company with a number of processes and systems for ethanol and biodiesel production to its credit.

Greenline Industries

Greenline Industries manufactures biodiesel production equipment.

Green Tech America

Green Tech America, Inc. (GTA) is in the business of developing and commercializing an yeast-based cellulosic ethanol technology that was pioneered by Dr. Nancy Ho at Purdue University. Cellulosic biomass (corn cobs and stover, wheat and rice straws, wood, grasses, municipal paper wastes, etc) is renewable and abundantly available in the United States. The application of cellulosic ethanol to transportation will help solve the company's Nation's energy problems, strengthen the company's economy, save the company's environment, and have a beneficial impact on the company's society. GTA is dedicated to making the production of cellulosic ethanol a reality in this country. The goal of GTA is to establish a cutting-edge company that supports and collaborates with ethanol producers to make the production of cellulosic ethanol a highly profitable business. Based on the Cellulosic Ethanol Yeast Technology developed by Dr. Ho and her colleagues at Purdue University, GTA will optimize the technical details and establish a blueprint for cellulosic ethanol production. The "blueprint" will then be licensed to other ethanol producers throughout the US and around the world to establish franchises for cellulosic ethanol production.GTA will provide cells, enzymes, chemicals, project management and technical support to the cellulosic ethanol producers, particularly to the numerous newly established corn-ethanol farmer-owned plants. The goal is to transform such plants to produce both corn- and cellulosic-ethanol. However, GTA's main business at the present time is to help the Purdue researchers engineer the yeast to produce important industrial products that can be produced alone or co-produced during ethanol production. Most importantly, the resulting yeasts can efficiently produce these co-products during the production of ethanol using sugars from both grain and cellulosic biomass as feedstocks.The Saccharomyces co-production technology to be marketed by GTA will make both the current grain-to-ethanol and the emergent cellulosic ethanol process more cost effective and profitable. The first generation of co-products that GTA plans to produce are substances important for animal feed, for the detergent industry, for the paper and fabric industry, as well as others. In addition, GTA will also market high valued products and residues, such as yeast extracts, from the yeast cells. More importantly, GTA will generate a range of other products produced from renewable resources for sustainable growth. GTA will also provide the R&D as well as the technical consultants for all small corn- or cellulosic-ethanol producers.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.